Poster Opportunities
Share your innovation with the NCODA community. Submit your abstract and poster to present at an NCODA conference, receive peer review and expert feedback, network with multidisciplinary oncology professionals, and have your accepted work published in the NCODA Oncology and Hematology Meeting Abstracts (NOHMA).
Digital Poster Sessions
The next digital poster presentation session will take place at the 2026 NCODA International Fall Summit, taking place October 28-30, 2026, in Orlando, FL.
Important Dates
- Poster Submission(s) Deadline: Friday, August 28, 2026
- Poster Acceptance Notifications: Friday, September 11, 2026
- Poster Session Dates: October 29-30, 2026
- International Fall Summit Dates: August 28-30, 2026
Submission Toolkit
Submission Process
- Submit Your Abstract
Share your research, case report, education/training, hot topic, or review abstract. - Abstract Review
Receive peer review, feedback, and your acceptance decision from the NCODA Poster Committee. Accepted abstracts are published in the NCODA Oncology & Hematology Meeting Abstracts. - Submit Your Poster
Once your abstract is accepted, submit your accompanying poster. - Poster Review
Receive poster feedback and your final acceptance decision from the NCODA Poster Committee. - Receive Your Presentation Schedule
Accepted presenters are assigned a poster session date and time. - Present at the NCODA 2026 International Fall Summit
Showcase your work in Orlando, Florida!
How to Submit
Posters may be submitted using the International Fall Summit Poster Submission form. Please note: only posters with an approved finalized abstract will be accepted.
If you are unable to submit your poster via Google Forms, you may email it as a PowerPoint (.pptx) or PDF format (16:9 ratio, 1920×1080 px) following the instructions below:
- Email subject line: 2026 Fall Summit Poster – [Poster Title]
- Send to: [email protected]
- CC: your designated committee lead
Committee Leads to Include in Your Communications
Physicians & Advanced Practice Providers – Corinne Shamedhdi: [email protected]
Pharmacists – Natasha Olson: [email protected]
Nurses – Mary Anderson: [email protected]
Pharmacy Technicians – Taryn Newsome: [email protected]
Residents & Students – Mustafa Abaciolgu: [email protected]
Industry Partners & Fellows – Jonathan Rivera: [email protected]
Research Focused (PhD, MS, MA) – Brian Sturgeon: [email protected]
For questions or assistance, please contact [email protected] and CC your designated poster committee lead.
Frequently Asked Questions
Who can submit a poster?
NCODA members and industry partners involved in oncology and hematology care or research are eligible to submit a poster. Encore presentations of previously presented work are also permitted, provided the content aligns with oncology and hematology care and/or research. All poster submissions must include a corresponding abstract that has been submitted to and approved by NCODA.
Who can author a poster?
Any NCODA member or industry partner.
What topics are acceptable?
Posters may cover any topic relevant to NCODA membership, including hematology, oncology, best practices in patient care, program initiatives, clinical research, and more. If your work supports oncology care or advances patient-centered practices, it’s welcome.
What topics can be submitted?
Posters may cover a variety of topics, including:
- Case Report
- Education/Training
- Hot Topic
- Original Research
- Review
Examples include practice site management, patient education techniques, program initiatives and outcomes, drug research, and NCODA projects or implementations.
Do you accept Trial-in-Progress (TIP) or Encore posters?
Yes, with conditions. NCODA currently accepts TIP and Encore posters if they are:
- Clearly identified as TIP or Encore during abstract and poster submission.
- Labeled as such in the disclaimer on the poster itself.
Please note: Priority approval is given to posters that are not TIPs or Encores, as space is limited. If space permits, TIPs and Encores will be considered.
Do I need to submit an abstract?
Yes. An abstract submission is required for your poster to be considered and accepted.
Do I need to submit an abstract to have my poster featured during the poster reception?
Yes. A submitted and approved abstract is required for your poster to be featured during the poster session.
How does submission work?
All submissions undergo peer review by the NCODA Poster Committee. NCODA does not hold publishing rights to external abstracts or information. Our goal is to provide a platform for NCODA members to share and learn.
Is there a submission fee?
No. There is no fee to submit your poster.
I missed the submission deadline—can I still present my poster?
If you missed the deadline, you may be eligible for the B-roll poster option, which allows your poster to be showcased during the event on a continuous loop (without a designated presentation time). For more information about B-roll submissions or other options, please contact [email protected].
What is the format of the poster session?
Posters will be displayed digitally on 65″ TV screens—no printed posters are required.
How does the poster reception work?
Presenters will be assigned a designated time block to present their poster. During this time, you’ll stand by your poster to discuss your work and answer questions from attendees.
Who can present on behalf of the first author?
A co-author may present if the first author cannot attend. If a pharmaceutical company employee will present on behalf of the author, their name and company must be included during submission. The designated presenter must be registered for the 2025 Spring Forum.
Are handouts permitted?
Yes. You are welcome to bring handouts for attendees. However, NCODA does not cover the cost of printing.
Will I be given a complimentary registration, travel, and hotel if I present a poster?
NCODA members residing in North America with an accepted abstract will receive complimentary registration, travel, and hotel accommodations for one presenter to support the onsite poster presentation. Travel dates will be assigned by NCODA.
For group poster submissions involving multiple NCODA members, complimentary registration, travel, and hotel accommodations will be provided for one designated presenter only. Additional presenters must register separately once conference registration opens and follow the standard registration process.
Industry partners, please note that complimentary registration, airfare, and hotel accommodations for poster presenters are included as part of NCODA membership benefits. Enrollment and travel coordination will be managed through the partner registration process.
How should I format my poster?
Posters must follow the formatting guidelines outlined in the Poster Submission Guidebook. Key points include:
- 16:9 ratio (1920×1080 px, 300 dpi)
- PowerPoint (.pptx) or PDF format
- Professional, high-contrast color schemes
- Clear labels on graphs, charts, and visuals
- For full details, please refer to the guidebook.
Am I required to use the NCODA poster template?
No. The NCODA poster template is not required. It is simply provided as a resource to help you get started. If you have an existing company or organization poster, you are welcome to use your own template.
Are posters published anywhere?
Yes. Posters and abstracts will be published:
NCODA’s Oncology and Hematology Meetings Abstracts (NOHMA)
Explore past research presented at NCODA meetings through the NOHMA. These collections showcase original research, quality improvement initiatives, innovative care models, and clinical experiences shared by members of the oncology and hematology community. Browse past abstracts and poster presentations for examples of previous submissions and explore the breadth of work presented during NCODA Poster Sessions.
NCODA’s Oncology and Hematology Meetings Abstracts Excellence Awards
Outstanding abstracts may also be recognized through the NCODA Oncology and Hematology Meeting Abstract Excellence Awards. Each year, one Member and one Student Member abstract are selected for their exceptional quality, relevance, and potential impact on oncology practice through a rigorous peer-review process.
